By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Fractal launches Vaidya 2.0, outperforming leading frontier models on Healthcare AI Benchmarks
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Fractal launches Vaidya 2.0, outperforming leading frontier models on Healthcare AI Benchmarks
Fractal launches Vaidya 2.0, outperforming leading frontier models on Healthcare AI Benchmarks
News

Fractal launches Vaidya 2.0, outperforming leading frontier models on Healthcare AI Benchmarks

Last updated: 19/02/2026 8:37 PM
Published: 19/02/2026
Share
SHARE

“Vaidya 2.0 is the first AI model to achieve a 50+ score on OpenAI’s HealthBench (hard), outperforming GPT-5 and Google’s Gemini Pro 3“

- Advertisement -

MUMBAI, India, Feb. 19, 2026 /PRNewswire/ — Fractal (www.fractal.ai), a global provider of artificial intelligence (AI) to Fortune 500® companies, today announced the launch of Vaidya 2.0, the next generation of its healthcare reasoning models available at Vaidya.ai. Debuting at the India AI Impact Summit 2026, Vaidya 2.0 scores 50.1 on HealthBench (hard), outperforming OpenAI’s GPT-5 and Google’s Gemini Pro 3 on this challenging benchmark.

- Advertisement -

Designed to power “Health Care Operating System” based workflows, Vaidya 2.0 bridges the gap between raw data and healthcare action. It is the first AI model in the world to achieve 50+ score on OpenAI’s HealthBench (hard) The model has been post-trained to deliver superior performance on a wide range of health care workflows. Read more about OpenAI’s HealthBench benchmark here.

- Advertisement -

Redefining the Healthcare Journey

- Advertisement -

Vaidya 2.0 significantly enhances model capabilities for enabling real-world healthcare use cases, including citizen facing use-cases such as:

- Advertisement -
  • Emergency Assist: Rapid triage and decision support in critical windows.
  • Symptom Checker: High-fidelity reasoning for citizen-facing wellness.
  • Patient Journey Assist: End-to-end support from first symptom to treatment adherence.

Vaidya 2.0 models also demonstrate a significant performance on MedExpert benchmark and introduce new capabilities to support Doctor Assist. These capabilities combined with the Administrator Assist capabilities from OpenAI HealthBench (hard) Health Data Tasks enhances ability to cater to medical professionals.

- Advertisement -

Scaling for the India AI Mission

- Advertisement -

As a partner selected under the ₹10,300+ crore India AI Mission, Fractal is at the forefront of building India’s sovereign AI capabilities. Vaidya 2.0 represents the first of many verticalized foundation models designed to solve the unique challenges of the Global South – frugal, scalable, and impact-driven.

- Advertisement -

“India has built strong digital health foundations over the past decade – from ABHA health IDs to Ayushman Bharat and e-Sanjeevani. The next step is adding reliable reasoning intelligence to those systems,” said Srikanth Velamakanni, Co-founder, Group Chief Executive & Vice Chairman, Fractal. “When you combine India’s digital health infrastructure with reliable reasoning AI, you unlock a new operating model for public health. At India’s population scale, intelligence must be accurate, transparent, and accountable. That is the problem Vaidya 2.0 is built to solve.”

- Advertisement -

“With Vaidya 2.0, we’ve moved from the knowledge-based foundation models to more advanced post-trained reasoning and agentic based healthcare models” added Suraj Amonkar, Chief AI Research & Platforms Officer, Fractal. “By ranking top globally, on the OpenAI HealthBench (hard) that focuses on realistic healthcare conversations and also showing leading performance on the MedExpert Benchmark that evaluates expert-level medical reasoning, Vaidya 2.0 models demonstrate a health-operating system approach that is not only more comprehensive, but also more reliable and accurate across a wide variety of healthcare workflows.”

- Advertisement -

Visit Us at the India AI Impact Summit

- Advertisement -

Fractal is showcasing Vaidya 2.0 and its suite of healthcare innovations at the India AI Impact Summit 2026, held at Bharat Pavilion inside the Bharat Mandapam, New Delhi.

- Advertisement -
  • Location: Bharat Mandapam, New Delhi
  • Hall No. 14 Pod No: P30
  • Dates: February 16 to February 20, 2026

For more information, visit www.vaidya.ai.

- Advertisement -

About Fractal

- Advertisement -

Fractal (NSE: FRACTAL) is a publicly listed global enterprise AI company with a vision to power every human decision in the enterprise.

- Advertisement -

Fractal’s suite of businesses includes Asper.ai (enabling interconnected decisions for revenue growth) and Analytics Vidhya (among the world’s largest data science communities). Fractal spun out Qure.ai, a global healthcare AI leader enhancing the rapid identification and management of tuberculosis, lung cancer, and stroke. Fractal’s dedicated AI Research team is focused on foundational AI advancements, including knowledge-based foundational models, reasoning-based systems, and agentic systems. The team has launched successful products, including MarshallGoldsmith.ai, Vaidya.ai, Kalaido.ai, and the open-source reasoning model Fathom-R1-14B and tool-based reasoning model Fathom-DeepResearch.

- Advertisement -

Fractal employs over 5,000 professionals across global locations, including the United States, Canada, the UK, the Netherlands, Ukraine, India, Singapore, South Africa, the UAE, and Australia. It has consistently earned recognition as one of India’s Best Companies to Work For (Top 100, 2025), a ‘Great Workplace’ for eight consecutive years, and as one of ‘India’s Best Workplaces for Women’ for five years running by the Great Place to Work® Institute. Fractal was also named a Leader in the 2025 Forrester Wave™ for Customer Analytics Service Providers and earned leadership positions in the Everest Group Peak Matrix Assessment 2025 for AI and Analytics Services, and Information Services Group’s 2024 assessments for Data Engineering and Data Science Services.

- Advertisement -

Photo: https://mma.prnewswire.com/media/2916660/OpenAI_HealthBench_Hard.jpg
Photo: https://mma.prnewswire.com/media/2916659/HealthBench_Hard_Emergency_Referrals.jpg
Photo: https://mma.prnewswire.com/media/2916658/HealthBench_Hard_Context_Seeking.jpg
Photo: https://mma.prnewswire.com/media/2916657/HealthBench_Hard_Hedging.jpg
Photo: https://mma.prnewswire.com/media/2916656/HealthBench_Health_Data_Tasks.jpg
Photo: https://mma.prnewswire.com/media/2916655/MedExpert.jpg

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/fractal-launches-vaidya-2-0–outperforming-leading-frontier-models-on-healthcare-ai-benchmarks-302692635.html

- Advertisement -
HPL Launches Smart Water Meter
CJ 4DPLEX and Nu Metro Cinemas Strengthen Partnership with First-Ever SCREENX in South Africa
DXRG Launches First Onchain Agentic Market: AI Agents Battle for Survival in Blockchain-Powered Arena
ADP Launches Unified Global Workforce Management Suite Across HCM Platforms
EquiLend Onboards EFG Hermes as First Saudi Arabia-Based Client on NGT Trading Platform
TAGGED:$2.0benchmarksfractalfrontierhealthcarelaunchesleadingmodelsnewsoutperformingvaidya
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
Health

RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)

GlobeNews Wire
GlobeNews Wire
19/10/2025
Stamus Networks Announces Production-Ready Clear NDR Community 1.0
UnionPay Enables 25 International Wallets to Support Weixin Pay QR Code in China’ Mainland
Multipl Reinventing Mutual Funds as New-Age Savings Accounts, Powered by Mutual Fund Returns and Brand Discounts; Partners with FundsIndia to Expand Spendvesting to MFDs Across India
Vnzymes Opens New European Office in Frankfurt to Accelerate Innovation in Animal Nutrition and Sustainable Agriculture
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?